If you havent read in the General Health Forum, the post on Coenzyme Q10, this should motivate you to do so. CoQ10 is vitally important for afibbers, especially, but actually every living being. It's important to understand why.
People taking statins are at high risk of having damage as a result of the drug blocking the production of this essential nutrient.
CoQ10 contributes 95% of the cellular ATP production to the heart muscle.
The bodys natural production of CoQ10 diminishes with age, as does the ability to convert the nutrient into ubiquinol. While everyone is different, research indicates CoQ10 production may begin to decline as early as age 20. For some, CoQ10 levels within the heart and kidneys have dropped more than 25 percent by age 40.
In Japan, CoQ10 has been an approved drug for serious heart problems for over 30 years.
Item 1
Low Plasma Coenzyme Q10 Levels and Breast Cancer Risk
Reference: "Low plasma coenzyme Q10 levels and breast cancer risk in Chinese women," Cooney RV, Dai Q, et al, Cancer Epidemiol Biomarkers Prev, 2011 April 5; [Epub ahead of print]. (Address: Office of Public Health Studies, University of Hawaii at Manoa, Hawaii, USA).
Summary: In a prospective, nested, case-control study involving 340 Chinese women with breast cancer and 653 age-matched controls, conditional logistic regression modeling, adjusted for age and age at first live birth, revealed a significant inverse association between breast cancer incidence and plasma coenzyme Q10 level, after eliminating cases diagnosed within one year of blood draw, independent of menopausal status. In addition, plasma levels of coenzyme Q10 were found to be significantly associated with circulating gamma-tocopherol and alpha-tocopherol levels.
The authors conclude, "This study reports an inverse relationship between circulating CoQ(10) and breast cancer risk, while the only other prospective study of CoQ(10) and breast cancer to date found a positive association. Lower levels of CoQ(10) in the SWHS population suggests that the two studies may not be contradictory and indicates a possible non-linear (U-shaped) association of CoQ(10) with risk."
[
cebp.aacrjournals.org]
Item 2
Diabetes: Type 2 diabetics suffer from elevated oxidative stress resulting in autonomic nervous system dysfunction. Japanese researchers found that as the day proceeded, so did levels of oxidative stress. This oxidative stress depleted ubiquinol levels faster than ubiquinone.
In fact, diabetics had approximately 75% less ubiquinol than the non-diabetic control group.
Item 3
In an advertising flyer that arrived in the mail promoting the benefits Coenzyme Q10 for heart health, several statements were offered as bullet points to grab ones attention (so you would buy their product)
however, the points are important to emphasize..
This statistic grabbed me and was attributed to observations by Peter H. Langsjoen, MD (cardiologist) and CoQ10 expert.
Cholesterol-lowering drugs damage and weaken the heart muscle in just 12 weeks, according to French researchers whose study was published in JAMA and indicated taking just 20 mg of Simvastatin a day lowered CoQ10 levels by 22% !!
Research shows that if CoQ10 levels drop below 75% - you can experience serious health problems which would include:
Out of control blood pressure
Irregular heart beats
Blood sugar imbalances
Immune deficiencies
Abnormal cell growth
High cholesterol
Breathing problems
Fatigue and exhaustion.
(I looked for the study but was not able to locate it. I did find several references to the lowering of CoQ10 by statins in other studies)
About 20-40% decrease in plasma ubiquinone was found in humans
treated with different statins [16-18].
Similarly, although atorvastatin and
pravastatin induced comparable changes in lipid profile in
humans with familial hypercholesterolemia, only the former
reduced serum CoQ significantly [20]. These data indicate
that lipophilic statins are more effective in reducing plasma
CoQ than hydrophilic compounds. Atorvastatin administered
for only 14 days decreased plasma CoQ by about 50% in
patients with hypercholesterolemia [21]. Passi et al. [22]
reported reducing effect of atorvastatin, simvastatin and
pravastatin on CoQ content not only in plasma but also in
peripheral blood lymphocytes.
Ubiquinone depletion induced by statin therapy may be
accompanied by impaired mitochondrial function, as
evidenced by reduced oxygen consumption and ATP
synthesis [23, 24]
Myocardial Performance
It has long been recognized that CoQ deficiency leads to
the impairment of myocardial contractility and that its
supplementation can improve cardiac function [147].
Heres the link
Current Drug Safety, 2009, 4, 209-228 209
1574-8863/09 $55.00+.00 © 2009 Bentham Science Publishers Ltd.
Adverse Effects of Statins - Mechanisms and Consequences
Jerzy Betowski*, Grayna Wójcicka and Anna Jamroz-Winiewska
Department of Pathophysiology, Medical University, Lublin, Poland
[
www.benthamscience.com]
Item 4
In Canada, they provide a warning about statin use
(this one is on Lipitor)
Effect on Ubiquinone (CoQ10) Levels
Significant decreases in circulating ubiquinone levels in patients treated with atorvastatin and other statins have been observed. The clinical significance of a potential long-term statin induced deficiency of ubiquinone has not been established. It has been reported that a decrease in myocardial ubiquinone levels could lead to impaired cardiac function in patients with borderline congestive heart failure
One wonders if anyone in Canada ie, doctors or patients, is aware of what that means
circulating ubiquinone
etc...
Item 5
There are 1600 published studies in medical journals offering scientific proof to confirm the power of CoQ10.
Item 6
Robert Rowen, MD, is well known for his newsletters. He publishes useful weekly tips as well. He does sell supplements, so you have to overlook the promo/plug for his brand at the end of this referenced article. The information is still valid and useful.
..." A 2005 study found that diabetics and people who have blood glucose handling issues have 75% less ubiquinol overall compared to healthy individuals. The same profound loss of ubiquinol was found in those with chronic liver disorders such as hepatitis, cirrhosis and hepatoma.
Dr. Rowen notes: By taking ubiquinol, you can reverse advanced heart disease. Most cardiologists dont believe you can rejuvenate dying heart cells. Ive told you in the past that most of these dead cells are really just hibernating. And when you give them the ability to produce energy, they come back to life. Remember what I said earlier without CoQ10 your cells cant produce energy. So hibernating cells are probably just deficient in CoQ10 (or ribose, see my website for more information). When you give them ubiquinol, youll be amazed at the improved performance of ones heart."
Source: [
healthydoctors.com]
Item 7
Concentration of CoQ10 by organ (ug/g-organ or ml) (round numbers)
Heart 120
Kidney 70
Liver 55
Muscle 40
Brain18
Pancreas 35
Lung 10
Thyroid 35
Testicle 15
Intestine 15
Skin (epithelial) 8
Skin (dermal) 6
Plasma 3
Item 8
Food equivalent sources of CoQ10 daily intake
15 pounds of peanut butter or
3 pounds of sardines or
2 pounds of chicken or
100 cups of broccoli
Item 9
Results with CoQ10 Supplementation
-- 87% restoration of heart function in 8 weeks.
Langsjoen HA, Langsjoen PH, Langsjoen PH, Willis R, Folkers K: Usefulness of coenzyme Q10 in clinical cardiology, a long-term study. In eds. Littarru GP, Battino M, Folkers K: Eighth International Symposium on Biomedical and Clinical Aspects of Coenzyme Q, The Molecular Aspects of Medicine, 1994; 15

165-S175.
-- Doubled survival rate in patients receiving CPR after heart stopped.
[
findarticles.com]
[
circ.ahajournals.org]
-- 46% reduction in angina attacks and improved capacity CoQ10
Journal of Clinical Pharmacology
[
www.lef.org] - Making old hearts young again
-- According to the University of Maryland Medical Center, using CoQ10 can enhance the effectiveness of various drugs
including
those for blood pressure, glaucoma and several heart medications since CoQ improves heart muscle function.
-- A Belgian study showed 51.8% of overweight patients studied were deficient in CoQ10. A sluggish metabolism is the result of CoQ10 deficiency. Adequate levels of CoQ10 can help you burn calories to produce energy.
Van Gaal, L., DeLeeuw, I., Vadhanavikit, S., Folkers, K., "Exploratory Study of Coenzyme Q10 in Obesity. Biomedical and Clinical Aspects of Coenzyme Q", Vol. 4, pp. 369-73, Elsevier Science Publishers B.V., 1984.
The medical journal Cardiovascular Drugs and Therapy indicated that by supplementing with CoQ10, the blood flow to your heart could improve by up to 91 percent! Its been reported that 75 percent of patients have fewer heart rhythm disturbances
66 percent of patients report diminished chest pain
and 50 percent of patients reduced their chance of a future heart disaster.
Item 11
Dosage recommendations vary depending on the condition being treated and the experience of the practitioner.
Recommended doses for common indications of coenzyme Q10 are:
Congestive Heart Failure (CHF): 50 100 mg in two or three divided doses1
Angina: 150 600 mg in two or three divided doses1
▪ HTN: 75-360mg/day in divided doses9
Mitochondria Disorders: 400 600mg/day in divided doses6
▪ Coenzyme Q10 deficiency: 150mg/day13
▪ Migraines prophylaxis: 150mg/day18
▪ Gum disease: 25 mg two times a day1
Parkinson Disease: 1200mg/day10
[
ucdenver.edu]
Item 12
Ubiquinol or Ubiquinone
which form for you?
Be sure it isnt a powdered or crystal form. The Q-gels types are specifically formulated to assist with absorption and may add vitamin E and D-limonene. The nano-particle is especially effective. The VESIsorb technology allows for a powdered, nano colloidal delivery system that is rapidly absorbable as noted by serum measurement. You have to study the labeling fine print. Drs. Best has one. [
www.douglaslabs.com]
It is found that in some individuals have difficulty converting ubiquinone to the active form, ubiquinol, especially those 40 and older. Both forms are used and recirculated continually by the body, but in some cases, using either a combination of both forms or high doses of the ubiquinol form are more effective. The ubiquinol form is more costly; yet if you take the other, it may not be effective.
Dr Langsjoens well-known study in congestive heart failure patients high doses of the ubiquinol form were needed for improvement.
Researchers at East Texas Medical Center found that patients with advanced congestive heart failure taking high doses of ubiquinone CoQ10 were not able to achieve adequate improvements in blood serum CoQ10 levels. When switched to ubiquinol, blood CoQ10 levels improved dramatically with a consequential improvement in clinical symptoms and left ventricular function. It is also being studied for its effects on TNF alpha, and therefore, inflammation. (see reference #7 in the General Health post Coenzyme Q10 The Spark of Life)
Kaneka holds the ubiquinol patent. Heres their website
[
www.kanekaqh.com]
There is now a book on Ubiquinol
[
www.kanekaqh.com]
[
www.kanekatexas.com]
References:
[
faculty.washington.edu]
Folkers K, Langsjoen P, Willis R, Richardson P, Xia L-J, Ye C-Q, Tamagawa H:
Lovastatin decreases coenzyme Q levels in humans. Proc Natl Acad Sci USA, 1990; 87: 8931-8934 [
www.pnas.org]
[15] Littarru GP, Langsjoen P. Coenzyme Q10 and statins: biochemical
and clinical implications. Mitochondrion 2007; 7(Suppl): S168-74.
[16] Folkers, K., Langsoen P, Willis R, et al. Lovastatin decreases
coenzyme Q levels in humans. Proc Natl Acad Sci USA 1990; 87:
8931-4.
[17] De Pinieux G, Chariot P., Ammi-Said M, et al. Lipid-lowering
drugs and mitochondrial function: effects of HMG-CoA reductase
inhibitors on serum ubiquinone and blood lactate/pyruvate ratio. Br
J Clin Pharmacol 1996; 42: 333-7.
[18] Kaikkonen J, Nyyssonen K, Tuomainen TP, Ristonmaa U, Salonen
JT. Determinants of plasma coenzyme Q10 in humans. FEBS Lett
1999; 443: 163-6.
[20] Kawashiri MA, Nohara A, Tada H, et al. Comparison of effects of
pitavastatin and atorvastatin on plasma coenzyme Q10 in
heterozygous familial hypercholesterolemia: results from a
crossover study. Clin Pharmacol Ther 2008; 83: 731-9.
[21] Rundek T, Naini A, Sacco R, Coates K, DiMauro S. Atorvastatin
decreases the coenzyme Q10 level in the blood of patients at risk
for cardiovascular disease and stroke. Arch Neurol 2004; 61: 889-
92.
[22] Passi S, Stancato A, Aleo E, Dmitrieva A, Littarru GP. Statins
lower plasma and lymphocyte ubiquinol/ubiquinone without
affecting other antioxidants and PUFA. Biofactors 2003; 18: 113-
24.
[23] Satoh K, Ichihara K. Effects of 3-hydroxy-3-methylglutaryl
coenzyme A reductase inhibitors on mitochondrial respiration in
ischemic rat hearts. Eur J Pharmacol 1995; 292: 271-5.
[24] Satoh K, Yamato A, Nakai T, Hoshi K, Ichihara K. Effects of 3-
hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on
mitochondrial respiration in ischaemic dog hearts. Br J Pharmacol
1995; 116: 1894-8.
[147] Singh U, Devaraj S, Jialal I. Coenzyme Q10 supplementation and
heart failure. Nutr Rev 2007; 65: 286-93.
Jackie